Anyone interested in biotech alliances and/or financing may be interested in two free online "webinars" by Deloitte Recap, provider of the "Recap" database.
The first describes some analysis by Mark Edwards on "effective" royalty rates in licensing transactions, both across time and across different types of alliances. It also gives some useful information about how Recap compiles its data.
The second (just yesterday) describes the recent trends in biotech financing - via alliances, VC, and public markets - and also contains some interesting information about how Recap distinguishes between platform and product biotech companies.
You can watch/listen to the online webinars by clicking the links below:
07/21/2009 - What is a reasonable royalty rate? Lessons from three decades of biopharma alliances
http://www.recap.com/webinar/recordings/09_07_21/Start.htm
08/18/2009 - What is the impact of the current market on biopharma alliances?
http://www.recap.com/webinar/recordings/09_08_18/Start.htm
**************************************
This message is from ENTREP which is sponsored by the Entrepreneurship Division of the Academy of Management.
Please do not post messages with attached files. Commercial messages or spammed messages are not allowed on the list. The use of auto-responder "out-of-office" messages may also lead to your removal from the list.
You can manage your subscription options, including joining or leaving the list here:
http://aomlists.pace.edu/scripts/wa.exe?SUBED1=entrep&A=1
If you have questions or need help, please contact Dr. John Bunch
jbunch@benedictine.edu.
Ventures HO!